Last reviewed · How we verify
Lactoserum (Dermacyd Femina®)
Lactoserum is a lactic acid-based vaginal cleanser that maintains vaginal pH and supports the natural lactobacillus flora.
Lactoserum is a lactic acid-based vaginal cleanser that maintains vaginal pH and supports the natural lactobacillus flora. Used for Vaginal hygiene and maintenance of normal vaginal flora, Prevention of vaginal dysbiosis and associated infections.
At a glance
| Generic name | Lactoserum (Dermacyd Femina®) |
|---|---|
| Sponsor | Sanofi |
| Drug class | Vaginal cleanser / pH regulator |
| Modality | Small molecule |
| Therapeutic area | Gynecology / Women's Health |
| Phase | FDA-approved |
Mechanism of action
Lactoserum contains lactic acid and lactose-derived components that help maintain the acidic pH of the vaginal environment, which is essential for preserving the natural lactobacillus microbiota. By supporting the physiological vaginal flora, it helps prevent dysbiosis and associated infections. This is a non-antibiotic approach to vaginal hygiene and health maintenance.
Approved indications
- Vaginal hygiene and maintenance of normal vaginal flora
- Prevention of vaginal dysbiosis and associated infections
Common side effects
- Local irritation
- Allergic contact dermatitis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactoserum (Dermacyd Femina®) CI brief — competitive landscape report
- Lactoserum (Dermacyd Femina®) updates RSS · CI watch RSS
- Sanofi portfolio CI